STAT

STAT+: The promise of radiopharmaceuticals smacks into safety concerns

STAT+: The promise of radiopharmaceuticals smacks into safety concernsWorldPing

Despite excitement over the potential of radiopharmaceuticals as cancer treatments, drug developers are hitting new hurdles.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news